Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Weekly Vinorelbine in Children With Progressive or Recurrent Low-Grade Gliomas

NCT01497860 is registered in ClinicalTrials.gov with Eugene Hwang as lead sponsor.

NCT NCT01497860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01497860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Weekly Vinorelbine in Children With Progressive or Recurrent Low-Grade Gliomas
Lead sponsor
Eugene Hwang
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2011
Completion date
July 31, 2017
Enrollment
13 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

low-grade glioma